Sawicki Mark W
Chief Scientific Officer
Sawicki Mark W has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 25, 2026.
On the most recent filing, Sawicki Mark W is listed as Chief Scientific Officer at Cryoport, Inc. Inside the rolling window, Sawicki Mark W reported no open-market purchases and 2 open-market sales totaling $37K in CYRX. The largest disclosed transaction in the window is a sale of 3,235 CYRX shares on Mar 16, 2026, worth $26K.
Companies traded
Other insiders at CYRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$37K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sawicki Mark W made?
Sawicki Mark W has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Sawicki Mark W trade?
Sawicki Mark W has filed SEC Form 4 disclosures for 1 company, including CYRX.
When was Sawicki Mark W's most recent SEC Form 4 filing?
Sawicki Mark W's most recent SEC Form 4 filing on Tracefour is dated Mar 25, 2026.
What is Sawicki Mark W's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sawicki Mark W is listed as Chief Scientific Officer.
What is Sawicki Mark W's total buy and sell value in the current window?
Inside the rolling retention window, Sawicki Mark W bought $0 and sold $37K based on SEC Form 4 filings.
What was Sawicki Mark W's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,235 CYRX shares on 2026-03-16, worth $26K, per SEC Form 4 filings.